MedTrace Logo

Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss

NCT05943860 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2023-07-13

No results posted yet for this study

Summary

The objective of this study is to assess the hair growth efficacy of a Food for Special Medicinal Purposes (FSMP) Pantovigar® vegan after 3 and 6 months of intake.

Conditions

  • Diffuse Hair Loss in Females

Interventions

DIETARY_SUPPLEMENT

Pantovigar® vegan

Oral application of 1 capsule three times a day (morning, noon, evening) for 6 months

Sponsors & Collaborators

  • Merz Therapeutics GmbH

    lead INDUSTRY

Principal Investigators

  • Merz Medical Expert · Merz Therapeutics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-13
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05943860 on ClinicalTrials.gov